Atlas Trials

Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

Clinical trial NCT00749320 · COMPLETED

Trial details

NCT number
NCT00749320
Sponsor
Beth Israel Deaconess Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2008-09-01
Primary completion
2019-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.